XML 144 R32.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Organization and Basis of Presentation (Details) - USD ($)
12 Months Ended
Feb. 23, 2022
Dec. 31, 2023
Dec. 31, 2022
Dec. 15, 2023
Organization and Basis of Presentation [Line Items]        
Reclassifications cash flow activity   $ 23,000    
Offering costs $ 17,100,000 $ 18,400,000  
Convertible preferred stock shares (in Shares) 5,626,365      
Proteomedix [Member]        
Organization and Basis of Presentation [Line Items]        
Subsidiary owned, percentage       100.00%
IPO [Member]        
Organization and Basis of Presentation [Line Items]        
Common stock (in Shares) 2,222,222      
Public of per share (in Dollars per share) $ 9      
Offering costs $ 2,900,000      
Onconetix [Member]        
Organization and Basis of Presentation [Line Items]        
Equity interest ownership percentage       100.00%